Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15,447,782
-
Total 13F shares
-
5,288,796
-
Share change
-
+43,868
-
Total reported value
-
$63,192,100
-
Price per share
-
$11.95
-
Number of holders
-
58
-
Value change
-
+$852,113
-
Number of buys
-
22
-
Number of sells
-
29
Institutional Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q4 2020
As of 31 Dec 2020,
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,288,796 shares.
The largest 10 holders included
Karpus Management, Inc., WELLS FARGO & COMPANY/MN, LAZARD ASSET MANAGEMENT LLC, MORGAN STANLEY, GAMCO INVESTORS, INC. ET AL, ROYAL BANK OF CANADA, Matisse Capital, Cornerstone Advisors, LLC, BENNICAS & ASSOCIATES, INC., and UBS Group AG.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.